{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T18:34:24Z","timestamp":1775759664248,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Fund of Luzhou city","award":["2024JYJ005"],"award-info":[{"award-number":["2024JYJ005"]}]},{"name":"Scientific Fund of Luzhou city","award":["2023JYJ011"],"award-info":[{"award-number":["2023JYJ011"]}]},{"name":"Fund Project of Southwest Medical University","award":["2021ZKMS001"],"award-info":[{"award-number":["2021ZKMS001"]}]},{"name":"Fund Project of Southwest Medical University","award":["2023QN115"],"award-info":[{"award-number":["2023QN115"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25270-3","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:55:11Z","timestamp":1763726111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the potential mechanisms of anti-pulmonary fibrosis effects of Luo Han Guo via network pharmacology, molecular docking, and experimental validation"],"prefix":"10.1038","volume":"15","author":[{"given":"Qinlin","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wencai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingbi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"25270_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-066354","volume":"377","author":"GY Liu","year":"2022","unstructured":"Liu, G. Y., Budinger, G. R. S. & Dematte, J. E. Advances in the management of idiopathic pulmonary fibrosis and progre ssive pulmonary fibrosis. BMJ 377, e066354 (2022).","journal-title":"BMJ"},{"key":"25270_CR2","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi, L., Collard, H. R. & Jones, M. G. Idiopathic pulmonary fibrosis. Lancet 389, 1941\u20131952 (2017).","journal-title":"Lancet"},{"key":"25270_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1378\/chest.09-1002","volume":"137","author":"ER Fern\u00e1ndez P\u00e9rez","year":"2010","unstructured":"Fern\u00e1ndez P\u00e9rez, E. R. et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: A population-based study. Chest 137, 129\u2013137 (2010).","journal-title":"Chest"},{"key":"25270_CR4","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00018-020-03693-7","volume":"78","author":"THG Phan","year":"2021","unstructured":"Phan, T. H. G. et al. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis. Cell Mol Life Sci 78, 2031\u20132057 (2021).","journal-title":"Cell Mol Life Sci"},{"key":"25270_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12916-016-0558-x","volume":"14","author":"B Rochwerg","year":"2016","unstructured":"Rochwerg, B. et al. Treatment of idiopathic pulmonary fibrosis: A network meta-analysis. BMC Med 14, 18 (2016).","journal-title":"BMC Med"},{"key":"25270_CR6","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1136\/thorax-2022-219391","volume":"78","author":"A West","year":"2023","unstructured":"West, A. et al. Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial. Thorax 78, 882\u2013889 (2023).","journal-title":"Thorax"},{"key":"25270_CR7","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/resp.13024","volume":"22","author":"JA Galli","year":"2017","unstructured":"Galli, J. A. et al. Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice\u202f: Tolerability and adverse drug reactions. Respirology (Carlton Vic). 22, 1171\u20131178 (2017).","journal-title":"Respirology (Carlton Vic)."},{"key":"25270_CR8","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/foods12071373","volume":"12","author":"J Duan","year":"2023","unstructured":"Duan, J. et al. Siraitia grosvenorii (Swingle) C Jeffrey\u202f: Research progress of its active components, pharmacological effects, and extraction method s. Foods. 12, 1373 (2023).","journal-title":"Foods."},{"key":"25270_CR9","first-page":"89","volume":"12","author":"C Li","year":"2014","unstructured":"Li, C. et al. Chemistry and pharmacology of Siraitia grosvenorii: A review. Chin J Nat Med 12, 89\u2013102 (2014).","journal-title":"Chin J Nat Med"},{"key":"25270_CR10","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1007\/s13197-018-3105-2","volume":"55","author":"H Liu","year":"2018","unstructured":"Liu, H., Wang, C., Qi, X., Zou, J. & Sun, Z. Antiglycation and antioxidant activities of mogroside extract from Siraitia grosvenorii (Swingle) fruits. J. Food Sci. Technol. 55, 1880\u20131888 (2018).","journal-title":"J. Food Sci. Technol."},{"key":"25270_CR11","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/jphp.13056","volume":"71","author":"G Chen","year":"2019","unstructured":"Chen, G. et al. Neuroprotective effect of mogrol against A\u03b21-42 -induced me mory impairment neuroinflammation and apoptosis in mice. J. Pharm Pharmacol. 71, 869\u2013877 (2019).","journal-title":"J. Pharm Pharmacol."},{"key":"25270_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2019.125400","volume":"303","author":"M Abdel-Hamid","year":"2020","unstructured":"Abdel-Hamid, M. et al. Bioactive properties of probiotic set-yogurt supplemented with Siraiti a grosvenorii fruit extract. Food Chem 303, 125400 (2020).","journal-title":"Food Chem"},{"key":"25270_CR13","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3390\/nu15020468","volume":"15","author":"M-S Kim","year":"2023","unstructured":"Kim, M.-S. et al. Siraitia grosvenorii extract attenuates airway inflammation in a murine model of chronic obstructive pulmonary disease induced by cig arette smoke and lipopolysaccharide. Nutrients 15, 468 (2023).","journal-title":"Nutrients"},{"key":"25270_CR14","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.3390\/nu15194140","volume":"15","author":"Y-Y Sung","year":"2023","unstructured":"Sung, Y.-Y. et al. Siraitia grosvenorii extract attenuates airway inflammation in a mouse model of respiratory disease induced by particulate matter 10 plus diesel exhaust particles. Nutrients 15, 4140 (2023).","journal-title":"Nutrients"},{"key":"25270_CR15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3390\/life13020555","volume":"13","author":"V Jaiswal","year":"2023","unstructured":"Jaiswal, V. & Lee, H. J. Pharmacological activities of mogrol: Potential phytochemical against different diseases. Life 13, 555 (2023).","journal-title":"Life"},{"key":"25270_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.152835","volume":"61","author":"Y-Y Sung","year":"2019","unstructured":"Sung, Y.-Y. et al. Siraitia grosvenorii residual extract attenuates ovalbumin-induced lun g inflammation by down-regulating IL-4, IL-5, IL-13, IL-17, and MUC5AC expression in mice. Phytomedicine 61, 152835 (2019).","journal-title":"Phytomedicine"},{"key":"25270_CR17","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","volume":"4","author":"AL Hopkins","year":"2008","unstructured":"Hopkins, A. L. Network pharmacology: The next paradigm in drug discovery. Nat Chem Biol 4, 682\u2013690 (2008).","journal-title":"Nat Chem Biol"},{"key":"25270_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphar.2019.00123","volume":"10","author":"R Zhang","year":"2019","unstructured":"Zhang, R., Zhu, X., Bai, H. & Ning, K. Network pharmacology databases for traditional Chinese medicine: Review and assessment. Front. Pharmacol. 10, 123 (2019).","journal-title":"Front. Pharmacol."},{"key":"25270_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/978-1-0716-0282-9_17","volume":"2114","author":"MG Aucar","year":"2020","unstructured":"Aucar, M. G. & Cavasotto, C. N. Molecular docking using quantum mechanical-based methods. Methods Mol. Biol. 2114, 269\u2013284 (2020).","journal-title":"Methods Mol. Biol."},{"key":"25270_CR20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu, G. et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183, 788\u2013824 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"25270_CR21","doi-asserted-by":"publisher","first-page":"1129709","DOI":"10.3389\/fphar.2023.1129709","volume":"14","author":"F Song","year":"2023","unstructured":"Song, F. et al. Uncovering the mechanism of Kang-ai injection for treating intrahepati c cholangiocarcinoma based on network pharmacology, molecular docking, and in vitro validation. Front Pharmacol. 14, 1129709 (2023).","journal-title":"Front Pharmacol."},{"key":"25270_CR22","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3389\/fphar.2020.01194","volume":"11","author":"X Lai","year":"2020","unstructured":"Lai, X. et al. Editorial: Network pharmacology and traditional medicine. Front Pharmacol. 11, 1194 (2020).","journal-title":"Front Pharmacol."},{"key":"25270_CR23","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.3390\/molecules24122277","volume":"24","author":"M Imran","year":"2019","unstructured":"Imran, M. et al. Kaempferol: A key emphasis to its anticancer potential. Molecules 24, 2277 (2019).","journal-title":"Molecules"},{"key":"25270_CR24","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1089\/dna.2019.4941","volume":"38","author":"H Liu","year":"2019","unstructured":"Liu, H. et al. Kaempferol modulates autophagy and alleviates silica-induced pulmonary fibrosis. DNA Cell Biol. 38, 1418\u20131426 (2019).","journal-title":"DNA Cell Biol."},{"key":"25270_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155090","volume":"121","author":"R Wang","year":"2023","unstructured":"Wang, R. et al. Kaempferol promotes non-small cell lung cancer cell autophagy via rest ricting Met pathway. Phytomedicine 121, 155090 (2023).","journal-title":"Phytomedicine"},{"key":"25270_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116773","volume":"317","author":"L Yan","year":"2023","unstructured":"Yan, L., Jiang, M.-Y. & Fan, X.-S. Research into the anti-pulmonary fibrosis mechanism of Renshen Pingfei formula based on network pharmacology, metabolomics, and verification of AMPK\/PPAR-\u03b3 pathway of active ingredients. J. Ethnopharmacol. 317, 116773 (2023).","journal-title":"J. Ethnopharmacol."},{"key":"25270_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2022.116037","volume":"444","author":"H Li","year":"2022","unstructured":"Li, H. et al. Mogrol suppresses lung cancer cell growth by activating AMPK-dependent autophagic death and inducing p53-dependent cell cycle arrest and apo ptosis. Toxicol Appl Pharmacol 444, 116037 (2022).","journal-title":"Toxicol Appl Pharmacol"},{"key":"25270_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153427","volume":"81","author":"H Liang","year":"2021","unstructured":"Liang, H. et al. Mogrol, an aglycone of mogrosides, attenuates ulcerative colitis by promoting AMPK activation. Phytomedicine 81, 153427 (2021).","journal-title":"Phytomedicine"},{"key":"25270_CR29","first-page":"1308","volume":"5","author":"C Liu","year":"2015","unstructured":"Liu, C. et al. Mogrol represents a novel leukemia therapeutic, via ERK and STAT3 inhi bition. Am. J. Cancer Res. 5, 1308\u20131318 (2015).","journal-title":"Am. J. Cancer Res."},{"key":"25270_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112273","volume":"247","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Zhou, G., Peng, Y., Wang, M. & Li, X. Anti-hyperglycemic and anti-hyperlipidemic effects of a special fracti on of Luohanguo extract on obese T2DM rats. J. Ethnopharmacol. 247, 112273 (2020).","journal-title":"J. Ethnopharmacol."},{"key":"25270_CR31","doi-asserted-by":"publisher","first-page":"12844","DOI":"10.1021\/acs.jafc.9b04600","volume":"67","author":"H Fuda","year":"2019","unstructured":"Fuda, H. et al. Flazin as a promising Nrf2 pathway activator. J. Agric. Food Chem. 67, 12844\u201312853 (2019).","journal-title":"J. Agric. Food Chem."},{"key":"25270_CR32","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1021\/np068074x","volume":"70","author":"T Akihisa","year":"2007","unstructured":"Akihisa, T. et al. Cucurbitane glycosides from the fruits of Siraitia gros venorii and their inhibitory effects on Epstein-Barr virus activation. J. Nat. Prod. 70, 783\u2013788 (2007).","journal-title":"J. Nat. Prod."},{"key":"25270_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2022.105326","volume":"80","author":"J Shen","year":"2022","unstructured":"Shen, J. et al. Mogroside V exerts anti-inflammatory effects on fine particulate matte r-induced inflammation in porcine alveolar macrophages. Toxicol. In Vitro 80, 105326 (2022).","journal-title":"Toxicol. In Vitro"},{"key":"25270_CR34","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.immuni.2016.01.001","volume":"44","author":"JL Larson-Casey","year":"2016","unstructured":"Larson-Casey, J. L., Deshane, J. S., Ryan, A. J., Thannickal, V. J. & Carter, A. B. Macrophage Akt1 kinase-mediated mitophagy modulates apoptosis resistan ce and pulmonary fibrosis. Immunity 44, 582\u2013596 (2016).","journal-title":"Immunity"},{"key":"25270_CR35","doi-asserted-by":"publisher","first-page":"e2866","DOI":"10.1210\/clinem\/dgab256","volume":"106","author":"N Wang","year":"2021","unstructured":"Wang, N. et al. LncRNA LPAL2\/miR-1287-5p\/EGFR axis modulates TED-derived orbital fibro blast activation through cell adhesion factors. J. Clin. Endocrinol. Metab. 106, e2866\u2013e2886 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"25270_CR36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s13402-022-00744-y","volume":"46","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. PKMYT1 inhibits lung adenocarcinoma progression by abrogating AKT1 activity. Cell Oncol. (Dordr) 46, 195\u2013209 (2023).","journal-title":"Cell Oncol. (Dordr)"},{"key":"25270_CR37","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1164\/rccm.202010-3832OC","volume":"206","author":"F Ahangari","year":"2022","unstructured":"Ahangari, F. et al. Saracatinib, A selective src kinase inhibitor, blocks fibrotic respons es in preclinical models of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 206, 1463\u20131479 (2022).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"25270_CR38","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.ajpath.2011.12.022","volume":"180","author":"DV Pechkovsky","year":"2012","unstructured":"Pechkovsky, D. V. et al. STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast ac tivation and differentiation in UIP\/IPF. Am. J. Pathol. 180, 1398\u20131412 (2012).","journal-title":"Am. J. Pathol."},{"key":"25270_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154680","volume":"112","author":"D Han","year":"2023","unstructured":"Han, D. et al. Hesperidin inhibits lung fibroblast senescence via IL-6\/STAT3 signalin g pathway to suppress pulmonary fibrosis. Phytomedicine 112, 154680 (2023).","journal-title":"Phytomedicine"},{"key":"25270_CR40","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.ymthe.2021.01.028","volume":"29","author":"J-M Li","year":"2021","unstructured":"Li, J.-M. et al. Therapeutic targeting of argininosuccinate synthase 1 (ASS1)-deficient pulmonary fibrosis. Mol. Ther. 29, 1487\u20131500 (2021).","journal-title":"Mol. Ther."},{"key":"25270_CR41","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.3390\/ijms23136936","volume":"23","author":"E Bertoli","year":"2022","unstructured":"Bertoli, E. et al. Acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer: How do we overcome it?. IJMS 23, 6936 (2022).","journal-title":"IJMS"},{"key":"25270_CR42","doi-asserted-by":"publisher","first-page":"19354","DOI":"10.18632\/oncotarget.15223","volume":"8","author":"R Li","year":"2017","unstructured":"Li, R. et al. Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells. Oncotarget 8, 19354\u201319364 (2017).","journal-title":"Oncotarget"},{"key":"25270_CR43","doi-asserted-by":"publisher","first-page":"1089812","DOI":"10.3389\/fphar.2023.1089812","volume":"14","author":"H Ji","year":"2023","unstructured":"Ji, H. et al. Metformin attenuates fibroblast activation during pulmonary fibrosis by targeting S100A4 via AMPK-STAT3 axis. Front. Pharmacol. 14, 1089812 (2023).","journal-title":"Front. Pharmacol."},{"key":"25270_CR44","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.2174\/1381612829666230911105931","volume":"29","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y. et al. Molecular mechanism of qingzaojiufei decoction in the treatment of pulmonary fibrosis based on network pharmacology and molecular docking. Curr. Pharm. Des. 29, 2161\u20132176 (2023).","journal-title":"Curr. Pharm. Des."},{"key":"25270_CR45","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/ddr.22048","volume":"84","author":"J Zhou","year":"2023","unstructured":"Zhou, J., Liu, Y., Chen, J., Xiong, N. & Yi, D. Kaempferol suppresses glioma progression and synergistically enhances the antitumor activity of gefitinib by inhibiting the EGFR\/SRC\/STAT3 s ignaling pathway. Drug Dev. Res. 84, 592\u2013610 (2023).","journal-title":"Drug Dev. Res."},{"key":"25270_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.13034","volume":"43","author":"M-H Hoang","year":"2019","unstructured":"Hoang, M.-H., Jia, Y., Lee, J. H., Kim, Y. & Lee, S.-J. Kaempferol reduces hepatic triglyceride accumulation by inhibiting Akt. J. Food Biochem. 43, e13034 (2019).","journal-title":"J. Food Biochem."},{"key":"25270_CR47","first-page":"7","volume":"47","author":"Z-Y Wang","year":"2022","unstructured":"Wang, Z.-Y., Wang, X., Zhang, D.-Y., Hu, Y.-J. & Li, S. Traditional Chinese medicine network pharmacology: Development in new era under guidance of network pharmacology evaluation method guidance. Zhongguo Zhong Yao Za Zhi 47, 7\u201317 (2022).","journal-title":"Zhongguo Zhong Yao Za Zhi"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25270-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25270-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25270-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T13:04:48Z","timestamp":1763730288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25270-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25270"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25270-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Southwest Medical University committee (Permit SWMU20230078). This study complied with the Regulations on the Management of Laboratory Animals issued by the National Science. All procedures were performed in accordance with the ethical standards of the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health and ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"41345"}}